References
- Murjan S, Saeedi S, Nabid MN. Comparison between novel star-like redox-sensitive amphiphilic block copolymer and its linear counterpart copolymer as nanocarriers for doxorubicin. Drug Dev Ind Pharm. 2020;46:646–658.
- Zhou Q, Zhang L, Yang TH, et al. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy. Int J Nanomedicine. 2018;13:2921–2942.
- Siegel RL, Miller KD, Jemal A. Colorectal cancer statistics. CA Cancer J Clin. 2017;67:177–193.
- Lorusso D, Bria E, Costantini A, et al. perception of chemotherapy side effects: expectations, doctor–patient communication and impact on quality of life – an Italian survey. Eur J Cancer Care. 2017;26:e12618.
- Demaria M, O'Leary MN, Chang J, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017;7:165–176.
- Praga C, Beretta G, Labianca R. Cardiac toxicity from antitumor therapy. Oncology. 1980;37:51–58.
- Hunter CA, Dolan TF, Coombs GH, et al. Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharm Pharmacol. 1988;40:161–165.
- Lian T, Ho RJY. Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001;90:667–680.
- Marzbali MY, Khosroushahi AY. Polymeric micelles as mighty nanocarriers for cancer gene therapy: a review. Cancer Chemother Pharmacol. 2017;79:637–649.
- Tiwari G, Tiwari R, Sriwastawa B, et al. Drug delivery systems: an updated review. Int J Pharm Investig. 2012;2:2–11.
- Zhao X, Chen Q, Li Y, et al. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm. 2015;93:27–36.
- Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7:771–782.
- Akash B, Ravindranath S. A review on novel drug delivery system: a recent trend. JDDT. 2019;9:517–521.
- Neha MD, Pranav BP, Anita RA, et al. Polymeric micelles as a drug carrier for tumor targeting. Chron Young Scientists. 2013;4:94–101.
- Greco F, Vicent MJ. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev. 2009;61:1203–1213.
- Madaan K, Kumar S, Poonia N, et al. Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci. 2014;6:139–150.
- Sercombe L, Veerati T, Moheimani F, et al. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.
- Chen J, Qiu X, Ouyang J, et al. pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery. Biomacromolecules. 2011;12:3601–3611.
- Yang HY, Jang MS, Gao GH, et al. Construction of redox/pH dual stimuli-responsive PEGylated polymeric micelles for intracellular doxorubicin delivery in liver cancer. Polym Chem. 2016;7:1813–1825.
- Luo Y, Yin X, Chen A, et al. Dual pH/redox-responsive mixed polymeric micelles for anticancer drug delivery and controlled release. Pharmaceutics. 2019;11:176.
- Zhang CY, Chen Q, Wu WS, et al. Synthesis and evaluation of cholesterol-grafted PEGylated peptides with pH-triggered property as novel drug carriers for cancer chemotherapy. Colloids Surf B Biointerfaces. 2016; 142:55–64.
- Alsuraifi A, Curtis A, Lamprou AD, et al. Stimuli responsive polymeric systems for cancer therapy. Pharmaceutics. 2018;10:136.
- Kocak G, Tuncer C, Bütün V. pH-Responsive polymers. Polym Chem. 2017;8:144–176.
- Cheung RCF, Ng TB, Wong JH, et al. Chitosan: an update on potential biomedical and pharmaceutical applications. Mar Drugs. 2015;13:5156–5186.
- Guan Y, Zhang Y. Boronic acid-containing hydrogels: synthesis and their applications. Chem Soc Rev. 2013;42:8106–8121.
- Gao Y-J, Qiao Z-Y, Wang H. Polymers with tertiary amine groups for drug delivery and bioimaging. Sci China Chem. 2016;59:991–1002.
- Croy SR, Kwon GS. Polymeric micelles for drug delivery. Curr Pharm Des. 2006;12:4669–4684.
- Chen B, Dai W, He B, et al. Current multistage drug delivery systems based on the tumor microenvironment. Theranostics. 2017;7:538–558.
- Hong L, Wang Z, Wei X, et al. Antibodies against polyethylene glycol in human blood: a literature review. J Pharmacol Toxicol Method. 2020;102:106678.
- Adams N, Schubert US. Poly(2-oxazolines) in biological and biomedical application contexts. Adv Drug Deliv Rev. 2007;59:1504–1520.
- Schanté CE, Zuber G, Herlin C, et al. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr. Polym. 2011;85:469–489.
- Labet M, Thielemans W. Synthesis of polycaprolactone: a review. Chem Soc Rev. 2009;38:3484–3504.
- Ashwinkumar N, Maya S, Jayakumar R. Redox-responsive cystamine conjugated chitin-hyaluronic acid composite nanogels. RSC Adv. 2014;4:49547–49555.
- Yan T, Li D, Li J, et al. Effective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(ε-caprolactone) copolymer micelle for combination cancer chemotherapy. Colloids Surf B Biointerfaces. 2016;145:526–538.
- Pommier Y, Leo E, Zhang H, et al. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol. 2010;17:421–433.
- Ashjari M, Kazemi M, Nazar Abi M, et al. Poly (isopropyl-oxazoline) micelle nanocarrier as dual-responsive prodrug for targeted doxorubicin delivery. J Drug Deliv Sci Technol. 2020;59:101914.
- Hu Y, He Y, Ji J, et al. Tumor targeted curcumin delivery by folate-modified MPEG-PCL self-assembly micelles for colorectal cancer therapy. Int J Nanomedicine. 2020;15:1239–1252.
- Hahn L, Lübtow MM, Lorson T, et al. Investigating the influence of aromatic moieties on the formulation of hydrophobic natural products and drugs in poly(2-oxazoline)-based amphiphiles. Biomacromolecules. 2018;19:3119–3128.
- Lübtow MM, Nelke LC, Seifert J, et al. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: physico-chemical characterization and evaluation in 2D and 3D in vitro models. J. Control. Release. 2019;303:162–180.
- Chen X, Sun J, Li H, et al. Curcumin-loaded nanoparticles protect against rhabdomyolysis-induced acute kidney injury. Cell Physiol Biochem. 2017;43:2143–2154.
- Liu F, Urban MW. Recent advances and challenges in designing stimuli-responsive polymers. Prog Polym Sci. 2010;35:3–23.
- Yoshino K, Yokoyama A, Yokozawa T. Well-defined star-shaped poly(p-benzamide) via chain-growth condensation polymerization: use of tetra-functional porphyrin initiator to optimize star polymer formation. J Polym Sci A Polym Chem. 2009;47:6328–6332.
- Pandey SK, Patel DK, Maurya AK, et al. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles . Int J Biol Macromol. 2016;89:99–110.
- Klaikherd A, Nagamani C, Thayumanavan S. Multi-stimuli sensitive amphiphilic block copolymer assemblies. J Am Chem Soc. 2009;131:4830–4838.
- Fischer D, Li Y, Ahlemeyer B, et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 2003;24:1121–1131.
- Domingos R, Baalousha MA, Ju-Nam Y, et al. Characterizing manufactured nanoparticles in the environment: multimethod determination of particle sizes. Environ Sci Technol. 2009;43:7277–7284.
- Seidi F, Jenjob R, Crespy D. Designing smart polymer conjugates for controlled release of payloads. Chem Rev. 2018;118:3965–4036.
- Desai S, Simonelli A, Higuchi W. Investigation of factors influencing release of solid drug dispersed in inert matrices. J Pharm Sci. 1965;54:1459–1464.
- Hsiue G-H, Wang C-H, Lo C-L, et al. Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(l-lactide) diblock copolymer for application in drug delivery. Int J Pharm. 2006;317:69–75.